A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head & Neck Squamous Cell Carcinoma
Primary Sponsor
EORTC
Collaborating Groups
TROG Cancer Research
Related Post
11 June, 2025
Trial Could Prove a Game-Changer for Treating High-Risk Skin Cancer
LATEST NEWS: 11 JUNE 2025 New findings from a
10 June, 2025
MRFF $1.5m grant for TROG-sponsored trial of new approach in lung cancer
LATEST NEWS: 10 JUNE 2025 A trial of a
